Specimen SS-F-TRP-821 // PUNGENT · IFI-P
Isovelleral Series III-PR-A
Zingiber officinale
Ginger
Target Trait
2.65×
fold-change
Isovelleral sesquiterpene TRPA1 agonist fold-change
Technical Specifications
SKU
SS-F-TRP-821
Genomic Edits
6
GC Content
47.6%
Construct Length
3,530 bp
Promoter System
Ubiquitin / T7
Expression System
Protoplast PEG-fusion
Host Strain
PEG-mediated
Receptor Target
TRPA1
IFI Score
265
Pathway Edits
- CYP88A6 (sesquiterpene hydroxylase) upregulation for germacrenol C-8 hydroxylation toward isovelleral skeleton in Zingiber officinale
- Germacrenol synthase integration for germacrenol C15-skeleton biosynthesis as isovelleral precursor
- FPPS upregulation for C15-FPP sesquiterpene precursor pool expansion in ginger metabolic background
- CYP450 aldehyde-forming oxidation enzyme for isovelleral C-8 and C-9 dialdehyde completion
- NAD(P)H oxidoreductase activity optimization for germacrenol to germacradienol oxidation intermediate
- Sesquiterpene export transporter upregulation for cytoplasmic accumulation of isovelleral-precursor intermediates
Key Interventions
IFI Subscale Profile
IFI Profile
Use Case
Tier III isovelleral-enriched platform for exotic TRPA1 agonist ingredient production, research-grade sesquiterpene dialdehyde supply for flavor receptor pharmacology, and specialty pungency applications in high-value culinary products requiring novel electrophilic warmth signatures distinct from conventional ITC or capsaicin pungency axes. Primarily suitable for flavor research institutions and specialty ingredient developers exploring sesquiterpene-class TRPA1 ligands.
License
$1499 · Tier III License
Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.
Already purchased?